These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8445300)

  • 1. Coronary microvascular fluid flux and permeability: influence of angiotensin II, aldosterone, and acute arterial hypertension.
    Reddy HK; Campbell SE; Janicki JS; Zhou G; Weber KT
    J Lab Clin Med; 1993 Mar; 121(3):510-21. PubMed ID: 8445300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.
    Brilla CG; Zhou G; Matsubara L; Weber KT
    J Mol Cell Cardiol; 1994 Jul; 26(7):809-20. PubMed ID: 7966349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration.
    Sun Y; Weber KT
    J Lab Clin Med; 1993 Oct; 122(4):404-11. PubMed ID: 8228554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone.
    Sun Y; Ratajska A; Zhou G; Weber KT
    J Lab Clin Med; 1993 Oct; 122(4):395-403. PubMed ID: 8228553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
    Holycross BJ; Li P; Jackson EK
    J Pharmacol Exp Ther; 1989 Aug; 250(2):442-53. PubMed ID: 2760838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary vascular hyperpermeability and angiotensin II.
    Reddy HK; Sigusch H; Zhou G; Tyagi SC; Janicki JS; Weber KT
    J Lab Clin Med; 1995 Sep; 126(3):307-15. PubMed ID: 7665980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis.
    Sørensen SS; Danielsen H; Jespersen B; Pedersen EB
    Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of brain renin-angiotensin on cardiovascular function and saline intake in awake dogs.
    Buckley JP; Jandhyala BS; Doursout MF; Huang YK; Chelly JE
    J Physiol (Paris); 1984; 79(6):485-90. PubMed ID: 6399316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of intestinal microvascular permeability associated with cardiopulmonary bypass.
    Cox CS; Allen SJ; Brennan M
    J Surg Res; 1999 May; 83(1):19-26. PubMed ID: 10210637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure.
    Jacobi J; Schlaich MP; Delles C; Schobel HP; Schmieder RE
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):418-22. PubMed ID: 10232503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium.
    Giacomelli F; Anversa P; Wiener J
    Am J Pathol; 1976 Jul; 84(1):111-38. PubMed ID: 937512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid homeostasis after heart transplantation: the role of cardiac denervation.
    Braith RW; Mills RM; Wilcox CS; Convertino VA; Davis GL; Limacher MC; Wood CE
    J Heart Lung Transplant; 1996 Sep; 15(9):872-80. PubMed ID: 8889982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional and structural behavior of the cardiovascular system of normotonic and spontaneously hypertensive rats following chemical sympathectomy and angiotensin administration].
    Matthias D; Moritz V; Engler E; Will-Shahab L; Schmidt R; Becker CH
    Acta Biol Med Ger; 1981; 40(12):1745-58. PubMed ID: 6808796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Emmett N; Socci RR; Eatman D; Fridie IL
    Clin Exp Hypertens; 2005 May; 27(4):355-67. PubMed ID: 15921072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
    Brilla CG; Weber KT
    J Lab Clin Med; 1992 Dec; 120(6):893-901. PubMed ID: 1453111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary lymphatic flow alterations during intracranial hypertension in sheep.
    Simon RP; Bayne LL
    Ann Neurol; 1984 Feb; 15(2):188-94. PubMed ID: 6703658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.